News in the Life Sciences Industry

OSLO, Norway, Nov. 5, 2019 /PRNewswire/ -- Photocure ASA., (OSE: PHO), The United States Centers for Medicare and Medicaid Services (CMS) has released its Final Rule maintaining the reimbursement code (A Code) for Cysview when used in hospital outpatient and other sites of care and improved the... Read more ››

CALGARY, Nov. 5, 2019 /CNW/ - Willow Biosciences Inc. ("Willow" or the "Company") (CSE:WLLW; OTCQB:CANSF) is pleased to announce that it has been approved to commence trading on The OTCQB® Venture Market (the "OTCQB"), beginning today, November 5, 2019, under the symbol... Read more ››

VANCOUVER, Nov. 5, 2019 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX: IN; OTCQX: IMLFF), today announced the filing of a Clinical Trial Application ("CTA") in the Netherlands to initiate a Phase 1 human clinical trial for INM-755 in healthy volunteers.

TORONTO, Nov. 5, 2019 /PRNewswire/ -- Field Trip Psychedelics Inc. ("Field Trip" or the "Company"), the world's first integrated company in legal psychedelics and psychedelic-assisted psychotherapy, is pleased to announce the appointment of of Dr. Michael Ehlers as a Strategic... Read more ››

SMITHS FALLS, ON, Nov. 5, 2019 /CNW/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NYSE: CGC) will release its financial results for the second quarter fiscal 2020 ended September 30, 2019 before financial markets open on November 14, 2019.

TORONTO, Nov. 5, 2019 /CNW/ - A randomized controlled trial has found that use of Baylis Medical's NRG® Transseptal Needle results in shorter time in achieving transseptal access, less transseptal attempts, and reduced exposure to radiation, compared to use of a conventional transseptal needle.

SEOUL, South Korea, Nov. 5, 2019 /PRNewswire/ -- Janssen Korea Ltd. and Johnson & Johnson Innovation LLC, in collaboration with the Seoul Metropolitan Government and Korea Health Industry Development Institute (KHIDI), today announced the awardees of the Read more ››

- MOMENTUM Phase 3 myelofibrosis clinical trial anticipated to launch in Q4 2019 -

LAVAL, Quebec, Nov. 4, 2019 /PRNewswire/ --

NASDAQ: CORV TSX: CORV

VANCOUVER, Nov. 4, 2019 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a biopharmaceutical company developing a proprietary biosynthesis manufacturing technology for the production of pharmaceutical-grade cannabinoids as well as a pipeline... Read more ››

--- FreshDirect founder and former CEO Jason Ackerman joins Board of Directors and named Executive Chairman